Telephone Genetic Counseling for High-Risk Women Undergoing <i>BRCA1</i> and <i>BRCA2</i> Testing: Rationale and Development of a Randomized Controlled Trial
Beth N. Peshkin(Georgetown University), Marc D. Schwartz(Guardia Civil), Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Tiffani A. DeMarco(Georgetown University), Diana Moglia(Good Samaritan University Hospital), Karen Brown(University of Leicester), Kristi D. Graves(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Andrea Forman(Fox Chase Cancer Center)
Cited by 48
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Impact of <i>BRCA1</i>/<i>BRCA2</i> Counseling and Testing on Newly Diagnosed Breast Cancer Patients
|Journal of Clinical Oncology|2004|250